Xbrane Biopharma AB (STU:7XB) YoY EPS Growth : 0.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xbrane Biopharma AB YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Xbrane Biopharma AB's YoY EPS Growth for the quarter that ended in Dec. 2024 was 0.00%.

Xbrane Biopharma AB's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was €-0.00.

Xbrane Biopharma AB YoY EPS Growth Historical Data

The historical data trend for Xbrane Biopharma AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB YoY EPS Growth Chart

Xbrane Biopharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

23.63

36.69

20.45

91.43

-216.67

Xbrane Biopharma AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EPS Growth	Get a 7-Day Free Trial															87.50	-2,600.00	-300.00	88.89	-

Xbrane Biopharma AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Xbrane Biopharma AB's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(-0.019	-	-0.006)	/	\| -0.006 \|
=	-216.67 %

Xbrane Biopharma AB's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (Q: Dec. 2024 )
=	(Earnings per Share (Diluted) (Q: Dec. 2024 )	-	Earnings per Share (Diluted) (Q: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2023 )) \|
=	(-0.003	-	-0.003)	/	\| -0.003 \|
=	0.00 %

Xbrane Biopharma AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Xbrane Biopharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (STU:7XB) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

XBRANE:Sweden 7XB:Germany

Address

Retzius vag 8, Solna, SWE, 171 65

Website

https://www.xbrane.com

Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company follows drugs on already approved biological drugs that can be introduced at a lower price after the patent expires on the original drug. The company has a patented protein production platform with greater productivity than standard systems for producing proteins in E.coli host cells. Xbrane's product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration.

Xbrane Biopharma AB Headlines

No Headlines